Upstate Active Clinical Trials
Study Title:Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
What is the purpose of the study?Lab study to develop a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia.
Upstate Institutional Review Board (IRB) Number:250590
Patient Age Group:Children
Principal Investigator:Karol H Kerr, MD
Who can I contact for more information?
Name: Beatriz Kovar